Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy
Abstract Introduction Pharmacotherapy such as selective serotonin reuptake inhibitors (SSRIs) or serotonin‐noradrenaline reuptake inhibitors is recommended for the treatment of anxiety disorders. Although there are patients with persisted symptoms of anxiety disorders who are treated with monotherap...
Saved in:
Main Authors: | Keisuke Mori (Author), Fumitoshi Kodaka (Author), Arisa Yamamoto (Author), Ryuichi Yamazaki (Author), Junpei Ishii (Author), Wataru Yamadera (Author), Hisatsugu Miyata (Author), Masahiro Shigeta (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between functional recovery and medication adherence in schizophrenia
by: Junpei Ishii, et al.
Published: (2022) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Decreased Growth with Serotonin Reuptake Inhibitors
by: J Gordon Millichap
Published: (2002) -
Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021) -
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012)